december, 2016

08decalldayalldayGenetic Rx Boston


Event Details

Genetic Rx will take place at Harvard Medical School and will bring together academics, key industry leaders and investors to discuss the emergence of new genetic medicines as well as the treatment of patients with rare and ultra-rare genetic diseases.

Speakers and Co-Hosts Include:
Sudhir Agrawal, President of Research, Idera Pharmaceuticals; Tom Barnes, CSO, Intellia Therapeutics; Paul BolnoPresident & CEO, WAVE Life Sciences; PJ Brooks, Program Director, NIH; Belen Carillo-Rivas, Global Clinical Submission Lead, Pfizer; Stacy Coen, Head, Rare Disease BD&L, Sanofi Genzyme; Olivier Danos, SVP, Cell & Gene Therapy, Biogen; Oliver FetzerCEO, Synthetic Genomics; Terence FlotteDean, UMass Medical School; Sandra Glucksmann, COO, Editas Medicine; JC Gutierrez-RamosCEO, Synlogic Therapeutics, Kathy HighPresident & CSO, Spark Therapeutics; James Jenson, CEO, CytoSite BioPharma; Edward KayeCEO, Sarepta; Sven KiliHead of Cell & Gene Therapy R&D, GlaxoSmithKline; Greg LaRosa, VP, CSO, Pfizer; Bill Lundberg, CSO, CRISPR Therapeutics; Sandy MacraePresident & CEO, Sangamo BioSciences; Ivana Magovcevic-Liebisch, SVP & Head of Global BD, Teva; Christian MeyerCMO, uniQure; Walter Ogier, President & CEO, Acetylon; Ed Pezalla, former National Medical Director, Pharmaceutical Policy & Strategy, Aetna; Jude Samulski, CSO & VP, Gene Therapy, Bamboo Therapeutics; Paula SoteropoulosCEO, Akcea Therapeutics; Arthur TzianabosCEO, Homology Medicines; Sue Washer, CEO, AGTC


All Day (Thursday)


Harvard Medical School, Joseph B. Martin Conference Center

77 Avenue Louis Pasteur Boston, MA 02115